Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Adamas Pharmaceuticals Inc (ADMS)
Adamas Pharmaceuticals Inc (ADMS) Actualités

Adamas Pharmaceuticals Inc (ADMS)

8,22

0,00

(0,00%)

Fermé 09 Juin 10:00PM

8,22

0,00

( 0,00% )

Avant marché: 2:00AM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Amended Statement of Ownership (sc 13g/a)

SCHEDULE 13G Amendment No. 1 ADAMAS PHARMACEUTICALS INC COMMON STOCK Cusip #00548A106 Check the appropriate box to...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:December 01,

Statement of Changes in Beneficial Ownership (4)

FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 24, 2021 Registration No. 333-253396 Registra...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 24, 2021 Registration No. 333-253396 Registra...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 24, 2021 Registration No. 333-253396 Registra...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on November 24, 2021 Registration No. 333-253396 Registra...

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File...

Current Report Filing (8-k)

0001328143 false --12-31 0001328143 2021-11-24 2021-11-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares ...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Adamas Pharmaceuticals

CloudMD Software & Servi...

WisdomTree Japan Equity ...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.